Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trial.
Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trial. Pol Arch Med Wewn. 2007 Sep; 117(9):389-90.